
Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Patrick Coffee, The Wall Street Journal
Web extension may be better at maxing out your credit card than the full capabilities of AI.
FTC alleged company vastly overstated the accuracy of its AI Content Detector tool.
Apple iPhone 16 users are asking Siri, where are the AI features that were touted in ads?
Get the dirt on this company’s “risk-free” trial.